| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.5008771983904797 2.7039793926166107 0.0068514538074062 0.983386165651878 0.2552166543258832 56 O75306,O75964,P14406,O43676,Q99643,Q9Y6M9,Q7KZN9,P00846,Q9Y6N1,Q9UDW1,P56134,P03886,O14949,P22695 14 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5920754557150989 2.525263600674333 0.0115611534664492 0.9990225739352828 0.3343772589396625 25 Q14739,Q15392,Q16850,Q15800 4 |
| Mitochondrial complex iv assembly 0.6802398554709859 2.496173786898336 0.0125541079300492 0.9994630532460168 0.3343772589396625 16 Q8N8Q8,P14406,Q7KZN9,Q9Y241,Q9Y6N1,Q9P0S2 6 |
| Adipogenesis 0.6687003081441172 2.4280496162289116 0.0151802663793987 0.9998901959344152 0.351602472000831 16 P14174,P43490,Q16822,Q9NZ45 4 |
| Sphingolipid metabolism integrated pathway 0.7259317868783257 2.1524477876007064 0.031362103366076 0.9999999943476648 0.4280707657952862 9 O15269,Q06136,P27544,Q13510,Q96G23,O95470 6 |
| Sphingolipid metabolism overview 0.7259317868783257 2.1524477876007064 0.031362103366076 0.9999999943476648 0.4280707657952862 9 O15269,Q06136,P27544,Q13510,Q96G23,O95470 6 |
| Sphingolipid metabolism in senescence 0.6863588902597473 2.1208550580242806 0.0339340016851104 0.9999999988410866 0.4280707657952862 11 P04062,Q13510,Q96G23,Q06136 4 |
| Sphingolipid pathway 0.6971995861505186 2.0898617933585686 0.0366302165361738 0.9999999997809011 0.4280707657952862 10 O15269,Q06136,P04062,Q13510,Q96G23,O95470 6 |
| Vitamin a and carotenoid metabolism 0.8831481851535885 1.9004384200415856 0.0573756090138046 0.9999999999999994 0.5671638436949386 4 Q8WTV0,P09455 2 |
| Ferroptosis 0.497409144163848 1.848189931741128 0.0645748714222667 1.0 0.6013534901198586 26 P45880,Q9NZ45,P09601,Q9UKU0 4 |
| 7oxoc and 7betahc pathways 0.6315626485015968 1.825154277962432 0.0679777512794517 1.0 0.6098311514182227 11 O14734,Q9UBM7,O15118 3 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7904272550182596 1.821342273700924 0.0685548442030552 1.0 0.6098311514182227 5 P49354 1 |
| Allograft rejection 0.7056780404218536 1.8126622272894095 0.06988393375293 1.0 0.6125121252462689 8 P08183,Q9BY49,P10321,P08670 4 |
| Mitochondrial complex iii assembly 0.6367767920380182 1.7722313503546014 0.0763561615449408 1.0 0.6222447619767743 10 P22695,Q6DKK2,Q9UDW1 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7759194247940239 1.7593182200969968 0.0785234735872189 1.0 0.6222447619767743 5 P07099,P09601 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7375471402240494 1.7519323340310922 0.0797854438673901 1.0 0.6222447619767743 7 Q14739,Q9UBM7,Q16850,Q15392 4 |
| Ccl18 signaling pathway 0.6444177079646457 1.7370593446324 0.0823766964688765 1.0 0.6222447619767743 9 P07196,P08670,P11166 3 |
| Omega3 omega6 fatty acid synthesis 0.7245139065600368 1.720038480827995 0.0854254470017243 1.0 0.6222447619767743 6 O15254 1 |
| Oxidation by cytochrome p450 0.729078763137625 1.713913778723996 0.0865445621156002 1.0 0.6222447619767743 7 Q16850,O43169 2 |
| Cytosine methylation 0.8344872308240654 1.7068918887038118 0.0878421487340745 1.0 0.6222447619767743 4 P48735 1 |
| Mitochondrial long chain fatty acid betaoxidation 0.5833171631454374 1.702066190068284 0.0887429610201775 1.0 0.6222447619767743 13 Q16836,Q9BY49,O43772,P23786 4 |
| Metabolism of spingolipids in er and golgi apparatus 0.7141036198133873 1.673003111409861 0.094326683523759 1.0 0.6388489020472772 6 Q06136,Q10472,O95470 3 |
| Novel intracellular components of rigilike receptor rlr pathway 0.6165617640262376 1.6636772114279117 0.0961769527135825 1.0 0.6440613912055637 10 Q92841,Q7Z434,Q13546,Q16539,Q86UT6 5 |
| Alzheimers disease and mirna effects 0.3726063318282746 1.608210520769893 0.1077890797592975 1.0 0.6472694627875495 80 P45880,P28070,P21796,Q13509,Q99436,O95197,P12235,P20618,Q96IX5,Q9BVA1,P60900,P28072,P48556,P62191,P49721,P28074 16 |
| Kennedy pathway from sphingolipids 0.699391855583458 1.6062250551059063 0.1082244701835191 1.0 0.6472694627875495 6 Q9HBU6,Q9BVG9 2 |
| Mitochondrial complex i assembly model oxphos system 0.4478174847774512 1.6026089756020705 0.1090210108889189 1.0 0.6472694627875495 31 O95139,O75306,Q9H845,O43676,Q9BUB7,Q9Y6M9,Q9NPL8,Q96CU9,P03886 9 |
| Nonalcoholic fatty liver disease 0.4010003165797831 1.5883871351170484 0.1121988247517316 1.0 0.6476830934695761 53 O95139,O75306,P14406,P51970,O43676,P49841,Q99643,Q9Y6M9,P49840,Q86Y39,O14949,P54646,P13073,Q9UDW1,O14548,P22695 16 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5516775889826099 1.580007089255536 0.1141052429770226 1.0 0.6476830934695761 14 P49354,O75844,P55209,O60725 4 |
| Influence of laminopathies on wnt signaling 0.5973044956897704 1.5592921300787006 0.1189272535616503 1.0 0.6686853124787133 10 P49354,O75844,O60725 3 |
| Ppar signaling pathway 0.5076252863986318 1.5302540407713692 0.125953859558499 1.0 0.6845420909961387 18 Q16822,O15254,Q9UKU0,P23786 4 |
| Nad biosynthetic pathways 0.921521189635378 1.524074020440244 0.127490221645254 1.0 0.6845420909961387 3 Q8IXJ6 1 |
| Nad metabolism 0.921521189635378 1.524074020440244 0.127490221645254 1.0 0.6845420909961387 3 Q8IXJ6 1 |
| Cholesterol biosynthesis pathway 0.5517493305268728 1.5145844733214104 0.1298776666675971 1.0 0.6880954389313174 13 Q16850,Q15800 2 |
| Serine metabolism 0.675633325577657 1.4976841831154484 0.134215323183207 1.0 0.6955855010190557 6 P00374,P34896,P34897 3 |
| Alzheimers disease 0.3637390226910473 1.4915280896409946 0.135822902060726 1.0 0.6978487036913164 79 P45880,P28070,P21796,Q13509,Q99436,O95197,P12235,P20618,Q9BVA1,P60900,P28072,P48556,P62191,P49721,P28074 15 |
| Nanomaterial induced apoptosis 0.7085592176464698 1.46750440836049 0.1422388909314653 1.0 0.7008018914241034 5 O95831,Q9NR28 2 |
| Fatty acid betaoxidation 0.4704888206690885 1.465595643650354 0.1427584787787115 1.0 0.7008018914241034 21 Q16836,O43772,Q9UKU0 3 |
| Spinal cord injury 0.4958688200305674 1.449696595508214 0.147143145552044 1.0 0.7025252690005496 18 P14174,P08670 2 |
| Folate metabolism 0.5194570630480887 1.44897294254343 0.1473451389436566 1.0 0.7025252690005496 15 Q99707,P34897,Q8WTV0,P00374,P34896 5 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.5404247396945354 1.4466391157123135 0.1479980248313734 1.0 0.7025252690005496 13 Q8IXJ6 1 |
| Familial partial lipodystrophy fpld 0.5844545962978959 1.420780357863833 0.1553806226748662 1.0 0.7107274999374628 9 P49354,O75844 2 |
| Prostaglandin and leukotriene metabolism in senescence 0.8364936276033574 1.4026186625922668 0.1607305836159858 1.0 0.720266374700207 2 P09960 1 |
| Metapathway biotransformation phase i and ii 0.4375960666305636 1.3963318258490476 0.1626145941887626 1.0 0.7218799721210734 27 Q7LGA3,Q6UW02,Q16850,P78417,P07099,Q8NCH0,Q9NRB3 7 |
| Circadian rhythm genes 0.4057118481232618 1.3933529668743123 0.1635130809334646 1.0 0.7218799721210734 40 P04818,Q14103,Q9BWF3,P49841,P43490,Q03164,P17844,Q9NRV9,Q15233,P00813,P54646,P54802 12 |
| Vitamin d metabolism 0.8809079601990035 1.3711120043012046 0.1703400434068214 1.0 0.7306027551754922 3 P04062,P38435 2 |
| Vitamin b12 metabolism 0.652471344127348 1.3646758414325095 0.1723549559539412 1.0 0.7306027551754922 7 Q8WTV0,Q96EY8,P34897,Q99707 4 |
| Fluoropyrimidine activity 0.5453847052608303 1.3428021995942898 0.1793360309819156 1.0 0.7484664516805859 11 Q06203 1 |
| Mecp2 and associated rett syndrome 0.4679924528837925 1.31417443546624 0.1887875094436311 1.0 0.7602524028946225 19 P35637,P31943,P52597,P67809,Q03518 5 |
| Proteasome degradation 0.3952864585184389 1.2715157280476186 0.2035452357145932 1.0 0.7729419994428761 39 P28070,Q99436,P20618,P10321,P60900,P28072,P48556,P62191,P49721,P28074 10 |
| Onecarbon metabolism and related pathways 0.4915289206692322 1.2694412509337438 0.204283731480761 1.0 0.7729419994428761 15 O15382,Q9HBU6,Q99707,P04818,P32929,P34897,P34896 7 |
| Sars coronavirus and innate immunity 0.8038545228473684 1.2667283262112303 0.2052524478685937 1.0 0.7729419994428761 2 Q7Z434 1 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.6232960929270481 1.2562385191512286 0.2090295050204333 1.0 0.7739809899362651 6 Q16539,Q7Z434,P42224 3 |
| Melatonin metabolism and effects 0.7982592477463218 1.2435061222182562 0.213681386330657 1.0 0.7757916734115017 2 P42892 1 |
| Vitamin b12 disorders 0.7137120196191875 1.217299350364485 0.2234903413937998 1.0 0.7853419996889313 4 Q9H3L0,Q96EY8 2 |
| Amyotrophic lateral sclerosis als 0.5084891224318426 1.201025745111822 0.2297412147954158 1.0 0.7853419996889313 12 Q16539,P07196,Q9BUN8 3 |
| Leptininsulin signaling overlap 0.78302766552689 1.180457463751954 0.2378183186781735 1.0 0.792232236738922 2 O14654 1 |
| Estrogen receptor pathway 0.7830276655268658 1.180457463751853 0.2378183186782136 1.0 0.792232236738922 2 Q15067 1 |
| Disruption of postsynaptic signaling by cnv 0.5767067113707911 1.180162675600156 0.2379355207655487 1.0 0.792232236738922 8 Q14168 1 |
| Progeriaassociated lipodystrophy 0.5195684247063258 1.130550834047794 0.25824419116241 1.0 0.8211744790075471 10 P49354,O75844 2 |
| Mitochondrial immune response to sarscov2 0.528890627680216 1.1221849496860667 0.261783810421869 1.0 0.8211744790075471 9 Q86UT6,Q7Z434,Q9Y6M9 3 |
| Oxidative phosphorylation 0.3872054934342718 1.1103049178576416 0.266867654638568 1.0 0.8250913455563127 34 O75306,O75964,Q9Y6M9,Q86Y39,P00846,P03886 6 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5624055786082525 1.1088242413922889 0.2675060107039055 1.0 0.8250913455563127 8 P31943 1 |
| Disorders of folate metabolism and transport 0.5608785502353859 1.1012056583267942 0.2708071596232577 1.0 0.8250913455563127 8 P00374,P34897,P04818 3 |
| 15q112 copy number variation syndrome 0.6840548097738551 1.0966669721643918 0.2727869993428748 1.0 0.8250913455563127 4 Q06787 1 |
| Oxysterols derived from cholesterol 0.5129993123325605 1.0940117329456336 0.2739498323896221 1.0 0.8250913455563127 10 O14734,Q9UBM7 2 |
| Camkk2 pathway 0.5571648635225506 1.0826785284683864 0.2789511376936118 1.0 0.8271386968427494 8 P09601 1 |
| Nitric oxide metabolism in cystic fibrosis 0.6797294074546861 1.079123393917524 0.280532723791512 1.0 0.827710412770996 4 Q86X55,O14744 2 |
| Urea cycle and related diseases 0.7522536524712206 1.0541172909615348 0.2918292207031501 1.0 0.8362029593224878 2 Q9Y619 1 |
| Endothelin pathways 0.5472343055752442 1.0331555783068187 0.3015310974191165 1.0 0.8469019927591246 8 P42892 1 |
| Glycerolipids and glycerophospholipids 0.5802959655086466 1.030366347849931 0.3028380642570896 1.0 0.8469019927591246 7 Q9HBU6 1 |
| Pi3kaktmtor vitd3 signaling 0.5738094087056125 1.0268404040078691 0.3044956205117473 1.0 0.8469019927591246 6 P54646 1 |
| Glycerophospholipid biosynthetic pathway 0.5743789339679248 1.0029655946867724 0.3158774617422959 1.0 0.8472590435076778 7 O14735,O95674,Q8WUK0,O15228 4 |
| Il4 signaling pathway 0.5064567732565328 1.0011502079360917 0.3167541946895729 1.0 0.8472590435076778 9 Q16539,P62993,P40763,P42224 4 |
| Vitamin d receptor pathway 0.4691214367018215 0.9676943373418596 0.3331970470159047 1.0 0.8472590435076778 12 P08183,Q5VV42 2 |
| Sarscov2 b117 variant antagonises innate immune activation 0.7308050979172924 0.9672397551579988 0.3334241925937133 1.0 0.8472590435076778 2 Q7Z434 1 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.4882596628441246 0.9564960990449118 0.3388216542765321 1.0 0.8517186300994951 10 P42224,P35613,Q7Z434,Q13546 4 |
| Nuclear receptors in lipid metabolism and toxicity 0.725831520049707 0.9472721844427354 0.3435001008658207 1.0 0.8530252504834549 2 P08183 1 |
| Ketogenesis and ketolysis 0.5591455105034872 0.9325771564963272 0.3510383323796318 1.0 0.8681279921089649 7 O43772,P23786 2 |
| Cardiac progenitor differentiation 0.7529224093283966 0.8946991859862496 0.3709479139596778 1.0 0.8976020966297734 3 Q16539 1 |
| Proteoglycan biosynthesis 0.5432395788312142 0.8860474716434543 0.3755919469139677 1.0 0.9026322595190512 6 Q8NCH0 1 |
| Nocgmppkg mediated neuroprotection 0.5367970754416096 0.8565944212968497 0.3916690699036711 1.0 0.929701802033497 6 P30536 1 |
| Interferon type i signaling pathways 0.4190845814953085 0.8340332326253889 0.4042622571739718 1.0 0.9339732671908476 16 P63244,Q16539,P46108,P42224,P23588,P40763 6 |
| Tryptophan metabolism 0.4233800792204456 0.827607337839034 0.4078929112878937 1.0 0.935016058183018 15 Q16836,Q15392,P40939 3 |
| Thermogenesis 0.3618523596378857 0.8069525787600443 0.4196938046396181 1.0 0.9532816817282386 29 O43772,Q9UKU0,P23786,P54646 4 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4406411717526949 0.7997451536817723 0.4238584658690993 1.0 0.9532816817282386 12 O75718,Q96AY3,Q32P28,Q9NVV0,P13674 5 |
| Apoptosis modulation by hsp70 0.7241407850765051 0.791546658096368 0.4286250602714221 1.0 0.9603779545931111 3 O95831 1 |
| Tca cycle aka krebs or citric acid cycle 0.4058057320456988 0.782686746226365 0.4338110871458256 1.0 0.9634531825293138 17 P48735 1 |
| Glycosaminoglycan degradation 0.5485165754443717 0.7689062118037001 0.4419489895418991 1.0 0.9683882270844554 5 P54802 1 |
| Congenital generalized lipodystrophy cgl 0.7117537313432798 0.7479833696425805 0.4544701886665208 1.0 0.9743317713857784 3 P62993,P31751 2 |
| Selenium micronutrient network 0.4293976273174202 0.73408710420333 0.462895652583523 1.0 0.9853064604992132 12 Q8WTV0,Q9C0D9,P32929,Q99707 4 |
| Oxidative stress response 0.4776591704117963 0.690460024031193 0.4899049410302378 1.0 1.0 8 Q16539,P09601 2 |
| Onecarbon metabolism 0.4005873597080308 0.681577605882473 0.4955060792679617 1.0 1.0 15 P00374,P34896,P34897,P04818 4 |
| Sulfation biotransformation reaction 0.6918894496757193 0.6793937890340188 0.4968883841940967 1.0 1.0 3 O43252 1 |
| Eicosanoid synthesis 0.6874999999999958 0.664472819531493 0.5063877396464329 1.0 1.0 3 Q9H7Z7,P09960 2 |
| Folatealcohol and cancer pathway hypotheses 0.6524712465029412 0.6642924529345878 0.5065031504458468 1.0 1.0 2 Q99707 1 |
| Photodynamic therapyinduced hif1 survival signaling 0.4257068275519176 0.6607438576453312 0.5087765925579402 1.0 1.0 11 P17858,P53985 2 |
| Histone modifications 0.492656598691587 0.6583871573785852 0.5102893855952888 1.0 1.0 6 Q9H7B4,O15047,Q01105 3 |
| Pilocytic astrocytoma 0.6502953061858776 0.6563295266067669 0.5116121235049176 1.0 1.0 2 P62993 1 |
| Type i interferon induction and signaling during sarscov2 infection 0.6821930383009112 0.6465567233101374 0.5179188744489016 1.0 1.0 3 Q7Z434 1 |
| Eicosanoid metabolism via cyclooxygenases cox 0.4821111649892959 0.6123262607406578 0.5403219183652888 1.0 1.0 6 O15254,Q14914 2 |
| Il10 antiinflammatory signaling pathway 0.5060036810949694 0.5928441775391268 0.5532854393511317 1.0 1.0 5 P42224,P09601 2 |
| Hepatitis c and hepatocellular carcinoma 0.428729355475648 0.5897999935065389 0.5553247470510747 1.0 1.0 9 Q16539,P62993,P40763 3 |
| Inclusion body myositis 0.6310226919490267 0.5872189877802244 0.5570566415492815 1.0 1.0 2 P05067 1 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.6596997626356385 0.5722632158082378 0.5671436660781688 1.0 1.0 3 P40763 1 |
| Nrf2are regulation 0.4707620315486573 0.5364538214903927 0.5916449427243631 1.0 1.0 7 P49841,P09601 2 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.6126826235623315 0.5240799006751192 0.6002229676110695 1.0 1.0 2 P08195 1 |
| Ethanol effects on histone modifications 0.4077650374810803 0.5206377576219446 0.6026191413103992 1.0 1.0 10 P00374,P04818 2 |
| Eicosanoid metabolism via lipooxygenases lox 0.4599721512604022 0.5179250853911247 0.6045105389320578 1.0 1.0 6 O15254,Q14914 2 |
| S1p receptor signal transduction 0.4377263360191915 0.5025908826047348 0.6152519407688737 1.0 1.0 8 Q13510,Q9NRA0,P63096 3 |
| Pdgfrbeta pathway 0.4561511944589604 0.5019982624868642 0.6156687431905787 1.0 1.0 6 P42224,P62993 2 |
| Riboflavin and coq disorders 0.4560778481513944 0.5016936978834605 0.6158829982512157 1.0 1.0 6 Q8NI60,O75208 2 |
| Degradation pathway of sphingolipids including diseases 0.4559414074014 0.5011272570772999 0.6162815650016555 1.0 1.0 6 P06865,P06280 2 |
| Kit receptor signaling pathway 0.3672165413889231 0.4985597432029175 0.6180895713001548 1.0 1.0 16 P42224,P62993,Q16539,P46108 4 |
| Copper homeostasis 0.4549588252060881 0.4970525833727757 0.6191519708335784 1.0 1.0 6 P49841,P05067,Q9Y6N1 3 |
| Sterol regulatory elementbinding proteins srebp signaling 0.3267385101472392 0.4841763169918378 0.6282607430951317 1.0 1.0 27 Q8WTV0,Q16850 2 |
| Cancer immunotherapy by pd1 blockade 0.628109452736313 0.4731508532806362 0.6361055581372277 1.0 1.0 3 P40763,Q06124 2 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.472261107090627 0.4611093537621621 0.6447201512103173 1.0 1.0 5 P42224,P62942 2 |
| Tgfbeta receptor signaling 0.472261107090627 0.4611093537621621 0.6447201512103173 1.0 1.0 5 P42224,P62942 2 |
| Physiological and pathological hypertrophy of the heart 0.4518964665813265 0.4571896049961129 0.6475347692964346 1.0 1.0 7 Q16539 1 |
| Biomarkers for pyrimidine metabolism disorders 0.4169766514442892 0.4098523699776045 0.6819142467918837 1.0 1.0 8 Q7LG56,Q9Y606 2 |
| Nrf2 pathway 0.3338259952407668 0.4057355566011518 0.684936913664596 1.0 1.0 20 Q14914 1 |
| Microglia pathogen phagocytosis pathway 0.4923794712286178 0.37658868628647 0.7064792968553553 1.0 1.0 4 P07948,O15143,O00443 3 |
| White fat cell differentiation 0.5592166614858645 0.3580763377051483 0.7202861863708243 1.0 1.0 2 Q04726 1 |
| Preimplantation embryo 0.4044078218299178 0.3558672377031096 0.72193999226614 1.0 1.0 8 Q99729 1 |
| Resistin as a regulator of inflammation 0.4854441395697098 0.354913686791726 0.7226542545518064 1.0 1.0 4 Q16539 1 |
| Vitamin dsensitive calcium signaling in depression 0.4161580153214956 0.3435577052991533 0.7311789368262778 1.0 1.0 6 Q8NB78 1 |
| Iron metabolism in placenta 0.5505129002175974 0.3340216759115546 0.7383632021154756 1.0 1.0 2 P21399 1 |
| Angiopoietinlike protein 8 regulatory pathway 0.299210341738805 0.3264881181793697 0.744055077555352 1.0 1.0 33 P11166,P22681,O00767,P49815,P49841,P13807,P31751,P49840,Q16539,O75955,O14654,P46108,P54646 13 |
| Pathways of nucleic acid metabolism and innate immune sensing 0.4271218690581311 0.3015476032708196 0.7629969560252592 1.0 1.0 5 Q7Z434,Q9Y3Z3 2 |
| Alpha 6 beta 4 signaling pathway 0.3649458433396121 0.2839397127739204 0.7764565820125713 1.0 1.0 9 Q16539 1 |
| Burn wound healing 0.3843723590228975 0.2739533903607045 0.784120440869871 1.0 1.0 8 Q99439,P08670 2 |
| Physicochemical features and toxicityassociated pathways 0.3312341695967423 0.2656993162067944 0.7904707900482921 1.0 1.0 15 P07737,P07196,P35080,P62993,P07197 5 |
| Leukocyteintrinsic hippo pathway functions 0.3995072555380393 0.2552755621222672 0.7985102734094496 1.0 1.0 7 Q16539 1 |
| Striated muscle contraction pathway 0.3991282689912802 0.2539368961102299 0.7995443098484527 1.0 1.0 7 P09493,P67936,P06753,P35609,P08670,O43707 6 |
| Transsulfuration and onecarbon metabolism 0.314474144675526 0.2508037420935166 0.801965848260523 1.0 1.0 19 Q99707,P04818,P34897,P00374,P34896 5 |
| Exrna mechanism of action and biogenesis 0.5135219148274843 0.2424960867878204 0.8083957886798021 1.0 1.0 2 Q9HAV4 1 |
| T cell receptor and costimulatory signaling 0.4036714370233405 0.2285368786102174 0.819228889597625 1.0 1.0 5 P49841,P49840 2 |
| Liver x receptor pathway 0.5063723966428444 0.2269128842459629 0.8204914831796546 1.0 1.0 2 O00767 1 |
| Rala downstream regulated genes 0.4376360808709096 0.2203912394232851 0.8255664676200856 1.0 1.0 4 Q96KP1,P63000,P11233 3 |
| Nuclear receptors metapathway 0.2766537324058421 0.2143814530452845 0.8302496037807543 1.0 1.0 46 Q15067,P09601,Q14914,P23786 4 |
| Transsulfuration pathway 0.3651207446192611 0.2008964588107888 0.8407795367264985 1.0 1.0 8 P25325,P32929,Q99707 3 |
| Robo4 and vegf signaling pathways crosstalk 0.4920733602735567 0.1978739148639079 0.8431437135585014 1.0 1.0 2 O94813 1 |
| Genes related to primary cilium development based on crispr 0.3243757248485981 0.1898461143956532 0.8494297188901458 1.0 1.0 13 A0AVF1,Q9C0F1,Q10713 3 |
| Mirna biogenesis 0.5136815920397937 0.1864926251434722 0.8520584616954514 1.0 1.0 3 P62826,Q9HAV4 2 |
| Corticotropinreleasing hormone signaling pathway 0.3134175849444789 0.1718926270114295 0.8635219431048995 1.0 1.0 15 P42892,P54646 2 |
| Mapk cascade 0.3634817667409288 0.1659293498784443 0.8682125497907531 1.0 1.0 6 Q16539 1 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.3807796725940318 0.165120073607538 0.8688494734226615 1.0 1.0 5 Q99707 1 |
| Regucalcin in proximal tubule epithelial kidney cells 0.3693217174859952 0.1365537898235954 0.8913835046102085 1.0 1.0 5 P42345,P28482,Q07812,Q8NE86 4 |
| Nephrotic syndrome 0.3095448310035019 0.1354141706657942 0.8922844207568352 1.0 1.0 14 Q14108 1 |
| 1q211 copy number variation syndrome 0.3270513752659124 0.1313443213355023 0.8955029321005319 1.0 1.0 9 Q9NPH0 1 |
| Il5 signaling pathway 0.3113940233854568 0.1306270949260035 0.8960703077256424 1.0 1.0 13 P42224,P62993,P49841,P40763 4 |
| Omega9 fatty acid synthesis 0.3492063492063506 0.1255882096201037 0.9000578964147978 1.0 1.0 6 O95864,O00767,P33121,O60488,P49327 5 |
| Immune response to tuberculosis 0.4767098968657199 0.1243820917828878 0.9010127519198176 1.0 1.0 3 Q03518 1 |
| B cell receptor signaling pathway 0.2952268955296435 0.1210801454213429 0.9036275551217818 1.0 1.0 18 P49841,P49840,Q16539,P46108,P62993 5 |
| Pyrimidine metabolism and related diseases 0.341167642515913 0.1191463285398796 0.9051594272607764 1.0 1.0 8 Q7LG56 1 |
| Angiotensin ii receptor type 1 pathway 0.4695273631840716 0.1141856378881867 0.9090906367455598 1.0 1.0 3 P63244,Q06124 2 |
| Exerciseinduced circadian regulation 0.2990131350587803 0.1122976915611236 0.9105873720946408 1.0 1.0 16 Q93062 1 |
| P53 transcriptional gene network 0.3072027975874409 0.1038226839039228 0.9173100645967798 1.0 1.0 12 Q709F0,Q7LG56,P11166 3 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.3045752665236982 0.1012725594773183 0.9193340985459912 1.0 1.0 13 O00303,P60228,P55010,O15372 4 |
| Arachidonate epoxygenase epoxide hydrolase 0.4087659309916148 0.084250822175218 0.9328570115361576 1.0 1.0 2 P34913 1 |
| Purine metabolism and related disorders 0.2942334925875275 0.0801748043270604 0.9360982288735258 1.0 1.0 15 P30520,Q06203,Q7LG56,P00813 4 |
| Oxidative damage response 0.4374999999999912 0.0758918311573442 0.939505155909692 1.0 1.0 3 O95429,P12004 2 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.3282724792616194 0.0733201508291214 0.9415513568128536 1.0 1.0 6 P49841 1 |
| Dna mismatch repair 0.2827492801369931 0.0731407644711539 0.9416941031516072 1.0 1.0 19 Q9UQ84 1 |
| Relationship between inflammation cox2 and egfr 0.3583203732503799 0.0656630562087053 0.9476460857815956 1.0 1.0 4 P31751,P28482,Q9H7Z7 3 |
| Gaba metabolism aka ghb 0.3602735467827253 0.0551545358373361 0.9560153489122932 1.0 1.0 2 P51649 1 |
| Apoptosis modulation and signaling 0.2861551571974868 0.0448883823369542 0.9641962770634268 1.0 1.0 15 P04632,Q9NR28 2 |
| Il9 signaling pathway 0.327490842694212 0.0431406620740716 0.9655894058079296 1.0 1.0 7 P42224,P62993 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.3924521389301935 0.0400796287211129 0.9680296426756316 1.0 1.0 3 P49841 1 |
| Il7 signaling pathway 0.325066451950788 0.037654733259644 0.969962968004488 1.0 1.0 7 P42224,P49841 2 |
| Tcell receptor tcr signaling pathway 0.2799243361484437 0.034019262036002 0.9728617907068596 1.0 1.0 17 Q16539,P46108 2 |
| G protein signaling pathways 0.28918210565064 0.0243377599534883 0.980583193955826 1.0 1.0 11 Q92667,O43823 2 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.3582089552238736 0.0242780965912743 0.9806307843692964 1.0 1.0 3 P40763,P28482 2 |
| Complement system in neuronal development and plasticity 0.292523364485988 0.0201232377485031 0.9839450628546936 1.0 1.0 9 Q9NR28,Q01518,P49327,O43464,Q15398,Q07812,Q5KU26,Q8N3R9 8 |
| Aryl hydrocarbon receptor pathway wp2873 0.3052608337400545 0.0185503616790109 0.9851998016545168 1.0 1.0 5 Q16543 1 |
| Interactions between loxl4 and oxidative stress pathway 0.3072139303482517 0.0129633801655789 0.9896570087994876 1.0 1.0 3 Q9BQ95,Q16543 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.2975412387177056 0.0121149798869798 0.9903338810481102 1.0 1.0 6 P07900,Q02750,P28482,Q16543,P24941 5 |
| Osteoblast differentiation and related diseases 0.3014578839926017 0.0097782156312764 0.9921982370414464 1.0 1.0 8 Q16539 1 |
| Il17 signaling pathway 0.2969213624693346 0.0083260457586398 0.9933568533905826 1.0 1.0 5 P49841 1 |
| Regulatory circuits of the stat3 signaling pathway 0.3006608216778353 0.0079434516729567 0.9936621092025548 1.0 1.0 8 Q16539,Q96B36 2 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.2842183205042066 0.0020106655272778 0.9983957220998024 1.0 1.0 10 Q16539,P49841,Q13546 3 |
| Insulin signaling in adipocytes diabetic condition 0.2874027993779108 0.0008245416923365 0.9993421109884928 1.0 1.0 4 O60343,P42345,P31751 3 |
| Insulin signaling in adipocytes normal condition 0.2874027993779108 0.0008245416923365 0.9993421109884928 1.0 1.0 4 O60343,P42345,P31751 3 |
|
|
